搜尋
Aerovate Therapeutics Inc
AVTE添加自選
2.680USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
77.68M總市值
虧損本益比TTM
關於 Aerovate Therapeutics Inc 公司
Aerovate Therapeutics Inc. 是一家臨牀階段的生物製藥公司。該公司專注於開發能夠顯著改善罕見心肺疾病患者生活的藥物。其最初的重點是推進 AV-101，這是一種用於治療肺動脈高壓 (PAH) 的伊馬替尼乾粉吸入劑型，這是一種影響美國和歐洲約 70,000 人的毀滅性疾病。口服伊馬替尼在 PAH 患者的主要終點、六分鐘步行距離和多個次要血流動力學終點方面也表現出統計學上的顯著改善。AV-101 使用乾粉吸入器輸送，旨在提供等於或高於口服劑量的肺部濃度，同時限制藥物的全身水平。PAH 是一種醫療需求尚未得到滿足的罕見病，其特徵是將血液從心臟右側輸送到肺部的血管壓力較高。
Aerovate Therapeutics Inc簡介
公司代碼AVTE
公司名稱Aerovate Therapeutics Inc
上市日期- -
CEOMr. Timothy P. Noyes
員工數量- -
證券類型Ordinary Share
年結日- -
公司地址930 Winter Street
城市WALTHAM
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編02451
電話16174432400
網址https://www.aerovatetx.com/
公司代碼AVTE
上市日期- -
CEOMr. Timothy P. Noyes
Aerovate Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+1.84%
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Mrs. Susan Fischer
Mrs. Susan Fischer
Executive Vice President - Development Operations
Executive Vice President - Development Operations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+1.84%
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
常見問題
Aerovate Therapeutics Inc的前五大股東是誰？
Aerovate Therapeutics Inc的前五大股東如下：Dr. Benjamin T. Dake, Ph.D.
有多少機構持有Aerovate Therapeutics Inc(AVTE)的股份？
截至2026Q1，共有241家機構持有Aerovate Therapeutics Inc的股份，合計持有的股份價值約為50.10M，占公司總股份的101.53% 。與2025Q4相比，機構持股有所增加，增幅為6166480.00。